DNA and RNA Sample Preparation Market

DNA and RNA Sample Preparation Market By Product Type (Workstations, Kits, Reagents and Consumables), By Application (Clinical Testing, Diagnostic Testing and Research Applications), By End User (Hospitals, Diagnostic Centers, Academic & Research Institutes, Forensic Science Laboratories and Contract Research Organizations (CROs)), and By Region - Global Market Report (2024 to 2034)

Analysis of DNA and RNA Sample Preparation Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

DNA and RNA Sample Preparation Market Outlook (2024 to 2034)

The global DNA and RNA sample preparation market is estimated to be worth US$ 1,967.5 million in 2024. The market is expected to register a CAGR of 5.7% from 2024 to 2034. The growth of the market over the forecast period is set to see the market size expand, reaching a projected value of US$ 3,413.8 million in 2034.

The growing need for personalized medicine, genetic testing, and advancements in molecular biology research is driving the market’s growth. With the increasing prevalence of diseases, there is a greater need for accurate and efficient methods of sample preparation to enable faster and more reliable analysis of genetic material.

The emergence of new technologies and techniques in the field of genomics is further driving the demand for DNA and RNA sample preparation. These methods include the extraction, purification, quantification, and amplification of nucleic acids from biological samples. The market is driven by the increasing demand for personalized medicine, diagnostics, and research applications.

Key Market Growth Drivers

  • Increasing R&D activities in the field of life science worldwide is expected to boost market expansion over the forecast period.
  • The growing concerns regarding infectious diseases are increasing the need for sample preparation tests, which is projected to drive the market over the forecast period.
Report Attributes Details
Estimated Market Value (2024E) US$ 1,967.5 million
Forecasted Market Value (2034F) US$ 3,413.8 million
Global Market Growth Rate (2024 to 2034) 5.7% CAGR
Clinical Testing Segment Growth Rate (2024 to 2034) 5.6% CAGR
North America Market Share (2024) 35.3%
East Asia Market Share (2024) 17.1%
Key Companies Profiled
  • Agilent Technologies, Inc.
  • QIAGEN
  • Merck Millipore
  • F. Hoffmann-La Roche
  • Illumina, Inc.
  • Tecan Group AG.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • PerkinElmer, Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Factors are Contributing to the Global Increase in Demand for DNA and RNA Sample Preparation?

“Growing R&D Activities in Life Sciences Driving Market Demand”

The growing research and development activities in various fields of life sciences are stimulating the market’s growth. DNA and RNA products and instruments are essential tools used in many research applications, including gene expression analysis, genotyping, sequencing, and cloning. With the advancement of technology, the demand for higher throughput and more accurate analysis has increased, leading to the development of new and innovative products and instruments. The global market for DNA and RNA preparation is expected to grow as research and development in life sciences are advancing with the emergence of new applications.

“Increasing Prevalence of Infectious Diseases Worldwide Fueling the Market”

The prevalence of infectious diseases across the world is a significant public health concern. These diseases can be caused by various pathogens such as bacteria, viruses, fungi, and parasites. Some common examples of infectious diseases include influenza, tuberculosis, malaria, and HIV/AIDS.

DNA and RNA sample preparation products and services are important tools in diagnosing and researching infectious diseases. DNA and RNA sequencing allow scientists to identify the specific genetic material of the pathogen, which can help in developing targeted treatments or vaccines. Additionally, sample preparation is often required to extract and purify the nucleic acids from the biological samples before sequencing.

Which Factors Present Challenges to the Expansion of the DNA and RNA Sample Preparation Market?

“High Cost of DNA and RNA Purification Process Hinders the Market Expansion”

The high cost of the DNA and RNA purification process is a major restraint for the DNA and RNA sample preparation market. The process involves several steps that are time-consuming and require specialized equipment and reagents, which can significantly drive up the cost. Additionally, the cost of sequencing and analyzing the purified DNA and RNA samples is also high. These factors make the overall cost of DNA and RNA sample preparation quite expensive, particularly for research labs and smaller biotech companies with limited budgets. This high cost can limit the accessibility of DNA and RNA sample preparation technology, which can ultimately hinder scientific progress in genomics and related fields.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Country-wise Insights

In line with the increasing sales in these regions, the DNA and RNA sample preparation market finds a considerable portion of its consumer base in North America and East Asia. North America is expected to hold 35.3% of the global market share in 2024. The market is expected to progress at a significant CAGR of 5.9% from 2024 to 2034, with the market share predicted to reach 35.9%.

East Asia holds a considerable share of the market. In 2024, the global market share for East Asia is tipped to be 17.1%. The market is expected to register a moderate CAGR of 6.2% in East Asia over the forecast period, and the market share of the region is projected to be 18.0%.

What is Propelling Sales of DNA and RNA Sample Preparation Kits in the United States?

“Advancements of Technology and Rising Prevalence of Chronic Diseases”

Attribute Details
Market Value (2034) US$ 1,040 million
CAGR (2024 to 2034) 6.0%

The value of the DNA and RNA sample preparation market in the United States is estimated to be US$ 580 million in 2024. The market is expected to register a CAGR of 6.0%, reaching a value of US$ 1,040 million by 2034.

The DNA and RNA sample preparation market share is expected to grow due to the rise in the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases in the United States. It is an essential process in molecular biology research, and it is used for studying gene expression, sequencing, and genotyping. Advancements in technology have led to the development of automated and efficient sample preparation systems, which have increased the accuracy and speed of research in the region. Additionally, the increasing funding for genomic research by governments and private organizations is expected to drive the growth of the DNA and RNA sample preparation market in the coming years.

Why is China Emerging as a Lucrative Country in the DNA and RNA Sample Preparation Market?

“Growing demand for Drug Discovery Research and Molecular Diagnostics in China.”

Attribute Details
Market Value (2034) US$ 741 million
CAGR (2024 to 2034) 9.4%

The value of the DNA and RNA sample preparation market in China is estimated to be US$ 301 million in 2024. The market is expected to register a robust CAGR of 9.4% over the forecast period, with a projected industry value of US$ 741 million by 2034.

The increasing demand for molecular diagnostics, drug discovery research, and genetic testing is fueling market growth. The market is expected to continue its growth trajectory in the coming years, driven by factors such as increasing investments in research and development activities, growing government initiatives to promote precision medicine, and rising awareness about the benefits of personalized medicine.

The expansion of large companies, particularly in the manufacturing sector, has also been a major factor in China's economic growth over the past few decades. However, this growth has come at a cost, with concerns about pollution and environmental degradation. It is believed that exposure to pollution and other environmental factors is expected to contribute to the rise in hematological diseases in China.

Category-wise Insights

Based on application type, the clinical testing segment is expected to account for 29.6% of the market share in 2024.

Why is the Clinical Testing Segment Dominating the DNA and RNA Sample Preparation Market?

“Increasing Need for Personalized Medicines and Accuracy of Diagnostic Tests”

Attribute Details
Market Share in 2024 29.6%

The clinical testing segment is expected to contribute 29.6% of the market share by product type in 2024. For the forecast period, the CAGR for examination gloves is marked to be 5.6%.

The increasing demand for personalized medicine requires the analysis of genetic information to determine the best course of treatment for individual patients. Additionally, the rise of infectious diseases and the need for faster and more accurate diagnostic tests have also led to an increase in demand for sample preparation products in the clinical testing segment. Finally, the increasing prevalence of chronic diseases such as cancer and Alzheimer's has also contributed to the growth of this segment.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Competitive Landscape

These companies are constantly working towards improving their products and services, expanding their customer base, and gaining a competitive edge in the market. With the increasing demand for sample preparation products and services, the market is expected to witness significant growth in the coming years, leading to even more competition among the players.

Some of the prominent companies in the DNA and RNA sample preparation industry are QIAGEN, Merck Millipore, F. Hoffmann-La Roche, Illumina, Inc., Tecan Group AG., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and Bio-Rad Laboratories Inc.

  • In 2022, The Digital LightCycler System, Roche's first digital polymerase chain reaction (PCR) system, was released. This next-generation technology is designed to diagnose numerous diseases in addition to correctly quantifying minuscule amounts of certain DNA and RNA targets that are normally undetected by standard PCR procedures.

Segmentation of DNA and RNA Sample Preparation Market Research

  • By Product Type :

    • Workstations
    • Kits
    • Reagents and Consumables
  • By Application :

    • Clinical Testing
    • Diagnostic Testing
    • Research Applications
  • By End User :

    • Hospitals
    • Diagnostic Centers
    • Academic & Research Institutes
    • Forensic Science Laboratories
    • Contract Research Organizations (CROs)
  • By Region :

    • North America
    • Europe
    • Latin America
    • East Asia
    • South Asia & Oceania
    • Middle East & Africa

- FAQs -

What is the Sales Outlook for the DNA and RNA Sample Preparation Market?

The sales outlook for the DNA and RNA sample preparation market is likely to be valued at US$ 1,967.5 million in 2024.

What is the Demand Forecast for DNA and RNA Sample Preparation Market for the Decade?

Demand for the DNA and RNA sample preparation market is projected to reach US$ 3,413 million by the end of 2034.

Which Application Segment is Leading the DNA and RNA Sample Preparation Market?

The clinical testing segment is leading the DNA and RNA sample preparation market by application, with an expected market share of 29.6% in 2024.

What is the Growth Projection for DNA and RNA Sample Preparation Market?

The DNA and RNA sample preparation market is projected to rise at a CAGR of 5.7% through 2034.

At What Rate is the Market in North America Predicted to Grow?

The North America market for DNA and RNA sample preparation is forecasted to expand at a CAGR of 5.9% through 2034.

- Also of Interest -

DNA Data Storage Market

DNA Data Storage Market Analysis by Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Chain Termination Sequencing, Sequencing by Ligation, and Nanopore Sequencing), by Deployment (Cloud and On-Premise), by End Use (Pharmaceutical, Hospitals and Clinics, Academic and Government Research Institutes, and Biotechnology) and by Region – Global Market Insights 2023 to 2033

Preimplantation Genetic Testing Market

Preimplantation Genetic Testing Market Analysis, By Test Type (Diagnostics, Screening), By Application (Embryo HLA Typing, IVF Prognosis, Late-Onset Genetic Disorders), By Technology (NGS-based, PCR-based, FISH-based), By Sales Type, By End Use, By Region - Global Market Insights 2022-2032

DNA Polymerase Market

DNA Polymerase Market Size, Share Report Analysis by Application (DNA Cloning, SNP Analysis, Next Generation Sequencing), by End-user (Research Centers, Academic Institutions, Biotechnology Centers) & Regional Forecast 2019-2029

DNA and RNA Sample Preparation Market

Schedule a Call